Subscribe To Our Free Newsletter |
Biocon edges higher after obtaining UK MHRA nod for diabetes drug Liraglutide
Biocon added 1.54% to Rs 260.55 after the company announced that it has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), U.K., for its complex formulation Liraglutide.